About Siemens Healthineers AG (SHL)
Siemens Healthineers AG is a Medical Devices company operating in the Healthcare sector. SHL has been publicly traded since 2019, giving it 7+ years of trading history.
Siemens Healthineers AG (SHL) has been publicly traded since 2019, making it a 7-year-old public company. It operates in the Medical Devices industry within the Healthcare sector. With a market capitalization of €43 billion, SHL is a large established company.
SHL trades on the German stock exchanges (XETRA/Frankfurt) and is classified as a large-cap-cap stock with a market capitalization of approximately €43 billion.
Key Statistics
- Current Price
- €38.78
- Market Cap
- €43.31B
- 52-Week High
- €53.24
- 52-Week Low
- €38.37
- Sector
- Healthcare
- Industry
- Medical Devices
SHL Investment Performance
SHL has declined 11.6% year-to-date in 2026. Over the past 5 years, a €1,000 investment in SHL would have grown to €921, representing a -7.9% total return. Since its IPO in 2019, a €1,000 investment would now be worth €1,394.
€1,000 Invested in Siemens Healthineers AG (SHL)
How much would €1,000 invested in SHL be worth today?
What would €1,000 invested in SHL 1 year ago be worth today?
A €1,000 investment in Siemens Healthineers AG (SHL) in 2025 would be worth €800 as of March 2026, representing a -20.0% total return.
What would €1,000 invested in SHL 3 years ago be worth today?
A €1,000 investment in Siemens Healthineers AG (SHL) in 2023 would be worth €776 as of March 2026, representing a -22.4% total return.
What would €1,000 invested in SHL 5 years ago be worth today?
A €1,000 investment in Siemens Healthineers AG (SHL) in 2021 would be worth €921 as of March 2026, representing a -7.9% total return.
What would €1,000 invested in SHL at IPO be worth today?
A €1,000 investment in Siemens Healthineers AG (SHL) at IPO would be worth €1,394 as of March 2026, representing a +39.4% total return.
Monthly Returns Heatmap
Over the past 7+ years (95 months), Siemens Healthineers AG (SHL) has averaged a monthly return of +0.58% with a median return of +1.52%. The stock had 56 positive months (59%) and 39 negative months (41%). The best month in SHL's history was May 2020 with a +15.6% return, while the worst was January 2022 at -13.8%. Historically, November tends to be the strongest month (averaging +6.9%), and August the weakest (-2.4%).
SHL's longest winning streak was 6 consecutive months of gains, while its longest losing streak was 4 consecutive months of losses. The best full year was 2021 with a cumulative return of +49.2%, and the worst was 2022 at -28.5%.
Annual Returns
Over 8 years of trading history, Siemens Healthineers AG (SHL) has delivered an average annual return of +5.34% with a median return of +0.45%. The compound annual growth rate (CAGR) is +2.64%. The stock posted gains in 4 years (50%) and losses in 4 years (50%).
SHL's best year was 2021 with a +59.40% gain, while the worst was 2022 at -27.91%. The longest streak of consecutive positive years was 2, and the longest losing streak was 2 years. SHL achieved double-digit gains (10%+) in 3 years. It suffered double-digit losses in 3 years.
| Year | Return | Start | End |
|---|---|---|---|
| 2026 | -11.59% | €43.87 | €38.78 |
| 2025 | -12.33% | €50.04 | €43.87 |
| 2024 | +0.92% | €49.58 | €50.04 |
| 2023 | +14.68% | €43.23 | €49.58 |
| 2022 | -27.91% | €59.97 | €43.23 |
| 2021 | +59.40% | €37.62 | €59.97 |
| 2020 | -0.03% | €37.63 | €37.62 |
| 2019 | +19.54% | €31.48 | €37.63 |
SHL Investment Analysis: Valuation, Risk & Dividends
Key factors to consider when evaluating Siemens Healthineers AG as an investment
Valuation
SHL currently trades at a trailing P/E ratio of 20.5, which is considered moderate relative to the broader market. The forward P/E of 14.7 suggests analysts expect earnings to be lower in the coming year.
Dividends
Siemens Healthineers AG pays a dividend to shareholders with a current yield of 2.58%.
Risk & Volatility
The stock's 52-week range is €38.37 to €53.24, and it currently trades near its 52-week low.
Frequently Asked Questions: SHL
What sector is SHL in? ▼
SHL operates in the Healthcare sector, specifically in the Medical Devices industry. This sector includes pharmaceutical companies, biotechnology firms, medical device manufacturers, and healthcare providers.
How has SHL performed historically? ▼
Over 8 years of trading history, SHL has posted gains in 4 years (50% of the time). The best year was 2021 with a +59.4% return. Past performance does not guarantee future results.
How can I invest in SHL? ▼
You can invest in SHL through any brokerage account that offers access to German exchanges. Popular options include commission-free brokers like Fidelity, Charles Schwab, or Robinhood (US), or international brokers like Interactive Brokers. You can buy individual shares or invest through ETFs that hold SHL.
Does SHL pay dividends? ▼
Siemens Healthineers AG pays a dividend to shareholders with a current yield of 2.58%.
What does Siemens Healthineers AG do? ▼
Siemens Healthineers AG is a Medical Devices company operating in the Healthcare sector.
What sector is SHL in? ▼
SHL operates in the Healthcare sector, specifically in the Medical Devices industry.
When did SHL go public? ▼
Siemens Healthineers AG went public in 2019, making it a 7-year-old public company as of 2026.
How much would €1,000 invested in SHL 5 years ago be worth today? ▼
A €1,000 investment in SHL five years ago would be worth approximately €921 today, representing a -7.9% return.
What is SHL's 3-year return? ▼
Over the past 3 years, SHL has returned -22.4%. A €1,000 investment would have grown to €776.
How much would €1,000 invested in SHL at IPO be worth today? ▼
If you invested €1,000 in SHL at its IPO in 2019, it would be worth approximately €1,394 today, a 39.4% return over 7 years.
Does SHL pay dividends? ▼
Yes, Siemens Healthineers AG pays a dividend with a current yield of 2.58%.
What is SHL's market cap? ▼
Siemens Healthineers AG has a market capitalization of €43 billion, classifying it as a large-cap company.
What is SHL's P/E ratio? ▼
SHL has a trailing P/E ratio of 20.5 and a forward P/E of 14.7, which measures how much investors are paying per dollar of earnings.
Last updated: 3/15/2026